Pfizer Inc.
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
Last updated:
Abstract:
In one aspect, the invention relates to use of a composition including a first polypeptide and a second polypeptide, wherein the composition elicits an immune response against Neisseria meningitis serogroup B strains expressing, for example, variants A02, A28, A42, A63, A76, B05, B07, B08, B13, B52 and B107.
Status:
Application
Type:
Utility
Filling date:
7 Feb 2020
Issue date:
21 Apr 2022